Lung and Breast Cancer Treatment

• Business
• Education
• Financial
• Healthcare
• Industrial
• Investment
• Management
• Marketing
• News
• Pharma & Biotech
• Science
• Security & Safety
• Technology
• United Kingdom

EMA Validates Marketing Authorisation Applications for AstraZeneca and Daiichi Sankyo’s Datopotamab Deruxtecan in Lung and Breast Cancer Treatment

(IN BRIEF) The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for datopotamab deruxtecan (Dato-DXd), developed by…